Friday December 15th 2017

Safety Profile of Delayed-Release Dimethyl Fumarate in Relapsing-Remitting Multiple Sclerosis (RRMS): Long-term Interim Results From the ENDORSE…

CONCLUSIONS: Sustained treatment with delayed-release DMF continues to demonstrate an acceptable safety profile in RRMS patients with no new or worsening safety signals.Study Supported by: Biogen IdecDisclosure: Dr. Phillips has received personal compensation for activities with Acorda Therapeutics, Biogen Idec, Genzyme Corp., Novartis, Teva Neuroscience, and Xenoport. Dr. Phillips has received research support from Roch Diagnostics Corp. Dr. Fox has received personal compensation for activities with Allozine, Avanir Pharmaceuticals, Biogen Idec, Novartis, Questcor, Teva Neuroscience, and Xenoport. Dr. Fox has received research support from Novartis. Dr. Selmaj has received personal compensation for activities with Genzyme Corp., Novartis, Ono Pharmaceutical, Roche Diagnostics Corp., Synth…

Source: 

Safety Profile of Delayed-Release Dimethyl Fumarate in Relapsing-Remitting Multiple Sclerosis (RRMS): Long-term Interim Results From the ENDORSE…

Leave a Comment

More from category

Germany’s Merck to make new bid to enter U.S. MS pill market
Germany’s Merck to make new bid to enter U.S. MS pill market

FRANKFURT (Reuters) - Germany's Merck KGaA is reviving plans to bring an oral multiple sclerosis (MS) treatment to the [Read More]

Researchers develop new method for quickly detecting signs of multiple sclerosis
Researchers develop new method for quickly detecting signs of multiple sclerosis

A METHOD for quickly detecting signs of multiple sclerosis has been developed by a University of Huddersfield research [Read More]

Terror survivors have increased risk of frequent migraine, tension headaches
Terror survivors have increased risk of frequent migraine, tension headaches

Survivors of a terror attack have an increased risk of frequent migraine and tension headaches after the attack, [Read More]

Scientists discover blood sample detection method for multiple sclerosis
Scientists discover blood sample detection method for multiple sclerosis

(University of Huddersfield) Researchers identified two natural biomarker compounds present in the blood. (Source: [Read More]

Study: The medical community isn’t prepared for the looming pandemic of neurodegenerative diseases like Parkinson’s
Study: The medical community isn’t prepared for the looming pandemic of neurodegenerative diseases like Parkinson’s

(Natural News) Parkinson’s disease is the second most common neurodegenerative disease plaguing people today, with an [Read More]